How to Safely and Responsibly Commercialize Your Health Data Cohorts with Pharma
Unlock the potential commercial value of your health data while ensuring compliance and security. Join us on 26 February 2025 to explore best practices for responsibly commercializing biobank data with pharma and biotech companies.
Learn how Lifebit’s Trusted Research Environment and Trusted Data Marketplace empower secure, scalable data sharing. Don’t miss the live demo showcasing how to bridge compliance with usability.
The growing demand for biobank data in precision medicine, drug discovery, and life sciences is undeniable. However, concerns around compliance, security, ethics, and governance challenges often create barriers to progress. This webinar will help you overcome these challenges by providing strategies to securely and responsibly commercialize sensitive biomedical data while meeting even the strictest compliance, governance and regulatory requirements.
At the same time, pharma and biotech firms seek seamless access to high-quality datasets and highly usable advanced analytics to accelerate R&D. Lifebit’s innovative solutions bridge this gap, enabling biobanks to commercialize data securely while empowering pharma companies to procure and use it with confidence.
What You’ll Learn:
-
Secure Data Commercialization Strategies: How biobanks can responsibly provide in-situ access to biomedical data while adhering to stringent compliance & security standards.
-
Understand best practice in enabling pharma: Discover how pharmaceutical companies needs to efficiently and flexibily access high-quality biobank data to accelerate precision medicine initiatives can be met.
-
Live Demo of Lifebit Solutions: See how Lifebit’s Trusted Research Environment streamlines secure data access and maximizes usability at scale while securing your data in situ.
Join us on 26 February 2025 to gain practical insights into overcoming data commercialization challenges, ensuring compliance, and unlocking new funding opportunities for your organization—all while driving innovation and therapeutic breakthroughs in life sciences that benefit patients. Register today!
The growing demand for biobank data in precision medicine, drug discovery, and life sciences is undeniable. However, concerns around compliance, security, ethics, and governance challenges often create barriers to progress. This webinar will help you overcome these challenges by providing strategies to securely and responsibly commercialize sensitive biomedical data while meeting even the strictest compliance, governance and regulatory requirements.
At the same time, pharma and biotech firms seek seamless access to high-quality datasets and highly usable advanced analytics to accelerate R&D. Lifebit’s innovative solutions bridge this gap, enabling biobanks to commercialize data securely while empowering pharma companies to procure and use it with confidence.
What You’ll Learn:
-
Secure Data Commercialization Strategies: How biobanks can responsibly provide in-situ access to biomedical data while adhering to stringent compliance & security standards.
-
Understand best practice in enabling pharma: Discover how pharmaceutical companies needs to efficiently and flexibily access high-quality biobank data to accelerate precision medicine initiatives can be met.
-
Live Demo of Lifebit Solutions: See how Lifebit’s Trusted Research Environment streamlines secure data access and maximizes usability at scale while securing your data in situ.
Join us on 26 February 2025 to gain practical insights into overcoming data commercialization challenges, ensuring compliance, and unlocking new funding opportunities for your organization—all while driving innovation and therapeutic breakthroughs in life sciences that benefit patients. Register today!